Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In one long-term study, called the SURMOUNT-1 trial, people taking tirzepatide lost up to 25% of their starting weight over a period of 72 weeks
It is a dual agonist, working on both the GLP-1 and GIP receptors, making it a promising candidate in the field of obesity and diabetes research
TB-500 is a 43-residue, 4963.4 g/mol thymosin beta 4 sequence acting through G-actin sequestration and integrin-linked kinase signalling, studied mainly in cardiac, corneal, dermal and skeletal muscle models
Ozempic is an FDA-approved prescription medication for the treatment of type 2 diabetes alongside diet and exercise
US$ 22.98
US$ 25.95
US$ 22.49
US$ 20.85
US$ 24.74
US$ 20.71
